Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Ovarian Epithelial

Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.

539 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Ovarian Epithelial trial results

Active, not recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory University Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • R.J.Zuckerberg Cancer Center Lake Success, New York, United States
View all 13 locations
View Trial Details
Active, not recruiting

The INFLUENCE of Cytoreduction on PRO in EOC

NCT03268876

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Sørlandet sykehus HF Kristiansand, Norway
  • Stavanger University Hospital Stavanger, Norway
View Trial Details
Active, not recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details
Completed

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

NCT00086567

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +25 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Evanston Northwestern University Hospital Evanston, Illinois, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Genomic BRCA and Extensive ovArian Cancer Testing

NCT04027868

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Centre de Radiothérapie et d'Oncologie de Moyenne Garonne (CROMG) Agen, France
  • Hôpital Privé d'Aix en Provence Aix-en-Provence, France
  • Centre Hospitalier Général d'Aix-en-Provence Aix-en-Provence, France
  • CHU Amiens Amiens, France
View all 137 locations
View Trial Details
Completed

A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT05613088

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
Locations
  • Local Institution - 0065 Sacramento, California, United States
  • Local Institution - 0025 San Francisco, California, United States
  • Local Institution - 0078 Whittier, California, United States
  • Local Institution - 0081 South Bend, Indiana, United States
View all 50 locations
View Trial Details
Completed

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02122185

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +57 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mitchell Cancer Institute - University of South Alabama Mobile, Alabama, United States
  • City of Hope Duarte, California, United States
  • NCH Medical Group- Northwest Community Hospital Arlington Heights, Illinois, United States
View Trial Details

Related conditions